Cambridge, Mass., USA - January 11, 2016, Cambridge, Mass., USA - Inhibikase Therapeutics, a pharma company, announced the election of Hilary Malone to its board.
Article continues below
Dr. Malone has over 20 years of experience in drug development and global regulatory affairs and currently serves as the Head of Global Regulatory Affairs for Sanofi, a position she has held since 2013.
Prior to joining Sanofi, Dr. Malone held roles as the Senior Vice-President and Head of Worldwide Regulatory Strategy for both Pfizer and Wyeth.
She has also worked in the small biotech arena with Reata Pharmaceuticals, where she was Chief Regulatory & Compliance Officer, from which she retired before joining Sanofi.
Dr. Malone has a B.Sc. (Hons.) and Ph.D. from the University of Dundee, Scotland and conducted post-doctoral research in Dundee and at the University of California, San Francisco, prior to entering the pharmaceutical industry.
Steven R. Gilman has retired from the Board.
Dr. Gilman was Executive Vice President, Research & Development and Chief Scientific Officer at Cubist Pharmaceuticals which was acquired in January, 2015 by Merck.
Prior to joining Cubist, he served as Chairman of the Board of Directors and CEO of ActivBiotics, a privately held biopharmaceutical company.
Previously, Dr. Gilman worked at Millennium Pharmaceuticals, Inc., where he held a number of senior leadership roles including Vice President and General Manager of the Inflammation franchise.
Prior to Millennium, he was Group Director at Pfizer Global Research and Development.
Dr. Gilman has also held scientific, business, and academic appointments at Wyeth, Cytogen Corporation, Temple Medical School, and Connecticut College.
Dr. Gilman was appointed to serve on the board of directors of Vericel, SYNEXIS, the Massachusetts Biotechnology Association, and the Penn State University Biotechnology Advisory Board.
Dr. Gilman received his M.S. and Ph.D. degrees in microbiology from Pennsylvania State University, his post-doctoral training at Scripps Clinic and Research Foundation, and received a B.A. in microbiology from Miami University of Ohio. ■